Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The objective of this project is to compare chemosensitivity between chemotherapy combinations in bone marrow aspirates using 3D organoid models. The investigators overarching hypothesis is that 3D organoids are ideal to test chemosensitivity in real time, to provide personalized medicine and guidance in the setting of relapsed hematologic malignancy and potentially other cancers.
Epistemonikos ID: ccba9b3d2a7b87ca35a86778110317c1e0daf589
First added on: May 22, 2024